A disruptive life saving solution for home monitoring and management of lung fl...
A disruptive life saving solution for home monitoring and management of lung fluid congestion in heart failure patients
Heart failure (HF) is one of the main causes of mortality and hospitalization worldwide, affecting around 26M people globally, and the most common cause of hospitalization for people over 65. Lung fluid congestion is one of the ma...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
EGM
A disruptive life saving solution for early detection of lun...
71K€
Cerrado
WELMO
Wearable Electronics for Effective Lung Monitoring
4M€
Cerrado
V-LAP
A revolutionary direct daily heart monitoring platform for...
3M€
Cerrado
NIRT MONITOR
ACCURATE EASY TO USE AND NON INVASIVE DEVICE FOR EARLY DETEC...
71K€
Cerrado
TED2021-131209B-I00
SISTEMA DE TELEASISTENCIA BASADO EN TEJIDOS INTELIGENTES PAR...
115K€
Cerrado
InCa
InCa Cardio Watch for Continuous Intra Cardiac Blood Press...
71K€
Cerrado
Información proyecto ReDS
Duración del proyecto: 2 meses
Fecha Inicio: 2019-10-30
Fecha Fin: 2019-12-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Heart failure (HF) is one of the main causes of mortality and hospitalization worldwide, affecting around 26M people globally, and the most common cause of hospitalization for people over 65. Lung fluid congestion is one of the main HF-related clinical conditions, which leads to a vicious cycle of repeated hospitalizations of HF patients. Strikingly, 1 in 4 patients are readmitted to the hospital within 30 days, and 1 in 2 patients within 6 months. The key challenge is to enable early detection, continuous monitoring and timely treatment of symptoms before the patient undergoes respiratory distress. In fact, current lung fluid monitoring practices are mostly inaccurate and inefficient, enabling detection only at very advanced stages, when symptoms cannot be prevented by simply changing the medication.
Sensible introduces ReDS™, a non-invasive home monitoring system for lung fluid congestion in HF patients. The monitoring procedure can be performed by the patient at home in just 90 seconds. The results are processed by an Artificial Intelligence (AI)-driven patient management platform and sent automatically to the physician. The unique proprietary AI algorithm supports physicians in identifying the best treatment based on each patients’ needs and general health status. ReDS™ is the first solution that enables accurate, remote monitoring and management of fluid congestion in HF patients after discharge.
During the phase 1 feasibility study, Sensible will define a minimum viable product, establish a sound go-to-market strategy and supply chain, and draft further development plans. During the second phase of the innovation project, Sensible will optimize the device engineering for home use, optimize the AI algorithm, scale-up device manufacturing and perform clinical validation with partner hospitals.